Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous effects of BRAF inhibitor therapy: a case series.
Mattei PL, Alora-Palli MB, Kraft S, Lawrence DP, Flaherty KT, Kimball AB. Mattei PL, et al. Among authors: kimball ab. Ann Oncol. 2013 Feb;24(2):530-537. doi: 10.1093/annonc/mds292. Epub 2012 Oct 3. Ann Oncol. 2013. PMID: 23035153 Free article.
Cumulative life course impairment: evidence for psoriasis.
Mattei PL, Corey KC, Kimball AB. Mattei PL, et al. Among authors: kimball ab. Curr Probl Dermatol. 2013;44:82-90. doi: 10.1159/000350008. Epub 2013 May 24. Curr Probl Dermatol. 2013. PMID: 23796812
Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age.
Kimball AB, Alora-Palli MB, Tamura M, Mullins LA, Soh C, Binder RL, Houston NA, Conley ED, Tung JY, Annunziata NE, Bascom CC, Isfort RJ, Jarrold BB, Kainkaryam R, Rocchetta HL, Swift DD, Tiesman JP, Toyama K, Xu J, Yan X, Osborne R. Kimball AB, et al. J Am Acad Dermatol. 2018 Jan;78(1):29-39.e7. doi: 10.1016/j.jaad.2017.09.012. Epub 2017 Nov 14. J Am Acad Dermatol. 2018. PMID: 29146147
Cutaneous manifestations of thyroid disease.
Doshi DN, Blyumin ML, Kimball AB. Doshi DN, et al. Among authors: kimball ab. Clin Dermatol. 2008 May-Jun;26(3):283-7. doi: 10.1016/j.clindermatol.2007.10.020. Clin Dermatol. 2008. PMID: 18640525 Review.
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.
Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J; ABT-874 Psoriasis Study Investigators. Kimball AB, et al. Arch Dermatol. 2008 Feb;144(2):200-7. doi: 10.1001/archdermatol.2007.63. Arch Dermatol. 2008. PMID: 18283176 Clinical Trial.
366 results